In our current study, when the pretreatment evaluations of the MDD group cases were compared with the first evaluations of the control group cases, there was no significant difference among FSH, E2, and AMH levels, while LH levels in the MDD group were significantly lower. This evidence concerns the gene BRD2 and major depressive disorder.